US Patent 11135296 Pharmaceutical compositions of fumaric acid esters
Patent 11135296 was granted and assigned to Arbor Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+244 characters)
Article
Patent abstract
Pharmaceutical compositions and dosage forms of (N,N-diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate and/or methyl 4-morpholin-4-ylbutyl (2E)but-2-ene-1,4-dioate, containing low levels of certain impurities are disclosed.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Sami Karaborni0
Suresh Kumar Manthati0
Wei Chen0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111352960
Date of Patent
October 5, 2021
0Patent Application Number
201805150
Date Filed
May 15, 2018
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11135296 Pharmaceutical compositions of fumaric acid esters
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11135296
Date of patent
October 5, 2021
Patent application number
20180515
Date Filed
May 15, 2018
Find more entities like US Patent 11135296 Pharmaceutical compositions of fumaric acid esters
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
